Cargando…

Orally ingestible medical devices for gut engineering

Orally ingestible medical devices provide significant advancement for diagnosis and treatment of gastrointestinal (GI) tract-related conditions. From micro- to macroscale devices, with designs ranging from very simple to complex, these medical devices can be used for site-directed drug delivery in t...

Descripción completa

Detalles Bibliográficos
Autores principales: Mandsberg, Nikolaj Kofoed, Christfort, Juliane Fjelrad, Kamguyan, Khorshid, Boisen, Anja, Srivastava, Sarvesh Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7255201/
https://www.ncbi.nlm.nih.gov/pubmed/32416112
http://dx.doi.org/10.1016/j.addr.2020.05.004
_version_ 1783539687151894528
author Mandsberg, Nikolaj Kofoed
Christfort, Juliane Fjelrad
Kamguyan, Khorshid
Boisen, Anja
Srivastava, Sarvesh Kumar
author_facet Mandsberg, Nikolaj Kofoed
Christfort, Juliane Fjelrad
Kamguyan, Khorshid
Boisen, Anja
Srivastava, Sarvesh Kumar
author_sort Mandsberg, Nikolaj Kofoed
collection PubMed
description Orally ingestible medical devices provide significant advancement for diagnosis and treatment of gastrointestinal (GI) tract-related conditions. From micro- to macroscale devices, with designs ranging from very simple to complex, these medical devices can be used for site-directed drug delivery in the GI tract, real-time imaging and sensing of gut biomarkers. Equipped with uni-direction release, or self-propulsion, or origami design, these microdevices are breaking the barriers associated with drug delivery, including biologics, across the GI tract. Further, on-board microelectronics allow imaging and sensing of gut tissue and biomarkers, providing a more comprehensive understanding of underlying pathophysiological conditions. We provide an overview of recent advances in orally ingestible medical devices towards drug delivery, imaging and sensing. Challenges associated with gut microenvironment, together with various activation/actuation modalities of medical devices for micromanipulation of the gut are discussed. We have critically examined the relationship between materials–device design–pharmacological responses with respect to existing regulatory guidelines and provided a clear roadmap for the future.
format Online
Article
Text
id pubmed-7255201
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-72552012020-05-28 Orally ingestible medical devices for gut engineering Mandsberg, Nikolaj Kofoed Christfort, Juliane Fjelrad Kamguyan, Khorshid Boisen, Anja Srivastava, Sarvesh Kumar Adv Drug Deliv Rev Article Orally ingestible medical devices provide significant advancement for diagnosis and treatment of gastrointestinal (GI) tract-related conditions. From micro- to macroscale devices, with designs ranging from very simple to complex, these medical devices can be used for site-directed drug delivery in the GI tract, real-time imaging and sensing of gut biomarkers. Equipped with uni-direction release, or self-propulsion, or origami design, these microdevices are breaking the barriers associated with drug delivery, including biologics, across the GI tract. Further, on-board microelectronics allow imaging and sensing of gut tissue and biomarkers, providing a more comprehensive understanding of underlying pathophysiological conditions. We provide an overview of recent advances in orally ingestible medical devices towards drug delivery, imaging and sensing. Challenges associated with gut microenvironment, together with various activation/actuation modalities of medical devices for micromanipulation of the gut are discussed. We have critically examined the relationship between materials–device design–pharmacological responses with respect to existing regulatory guidelines and provided a clear roadmap for the future. Elsevier B.V. 2020 2020-05-13 /pmc/articles/PMC7255201/ /pubmed/32416112 http://dx.doi.org/10.1016/j.addr.2020.05.004 Text en © 2020 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Mandsberg, Nikolaj Kofoed
Christfort, Juliane Fjelrad
Kamguyan, Khorshid
Boisen, Anja
Srivastava, Sarvesh Kumar
Orally ingestible medical devices for gut engineering
title Orally ingestible medical devices for gut engineering
title_full Orally ingestible medical devices for gut engineering
title_fullStr Orally ingestible medical devices for gut engineering
title_full_unstemmed Orally ingestible medical devices for gut engineering
title_short Orally ingestible medical devices for gut engineering
title_sort orally ingestible medical devices for gut engineering
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7255201/
https://www.ncbi.nlm.nih.gov/pubmed/32416112
http://dx.doi.org/10.1016/j.addr.2020.05.004
work_keys_str_mv AT mandsbergnikolajkofoed orallyingestiblemedicaldevicesforgutengineering
AT christfortjulianefjelrad orallyingestiblemedicaldevicesforgutengineering
AT kamguyankhorshid orallyingestiblemedicaldevicesforgutengineering
AT boisenanja orallyingestiblemedicaldevicesforgutengineering
AT srivastavasarveshkumar orallyingestiblemedicaldevicesforgutengineering